Javier A Sanchez

US Patent:

D549953, Sep 4, 2007

Filed:

Feb 7, 2007

Appl. No.:

29/272379

Inventors:

Javier A. Sanchez - Miami FL, US

Assignee:

Fior Enterprises, LLC - Miami FL

International Classification:

0303

US Classification:

D 3 5

US Patent:

20100049658, Feb 25, 2010

Filed:

Aug 22, 2008

Appl. No.:

12/197117

Inventors:

Javier Sanchez - Miami FL, US
Tai-Kei Cheung - Kowloon, HK
Gary Sweeney - Scottsdale AZ, US
Arthur Scott Gilbert - Scottsdale AZ, US
John Waycott - Phoenix AZ, US

International Classification:

H04L 9/00

US Classification:

705 64

Abstract:

Systems and methods for the secure processing of electronic transactions are disclosed. In accordance with an exemplary embodiment, a system and method for the secure processing of electronic transactions comprises: receiving, by a POS terminal, information for a financial transaction card; receiving, by the POS terminal, information for a financial transaction; encrypting, by the POS terminal, the financial card information and the financial transaction information into a first encrypted message; transmitting the first encrypted message to a regional chassis; encrypting, by the regional chassis, the first encrypted message into a second encrypted message; transmitting the second encrypted message to a central chassis; decrypting, by the central chassis, the second encrypted message into a decrypted message; and transmitting the decrypted message to a host processor for authorization.

US Patent:

20220304994, Sep 29, 2022

Filed:

Jun 14, 2022

Appl. No.:

17/839950

Inventors:

- Evanston IL, US
Javier Sanchez - Chicago IL, US
Jaime Guzman - Chicago IL, US
Enrico Zampese - Chicago IL, US
Daniel Galtieri - Chicago IL, US
Ema Ilijic - Chicago IL, US

International Classification:

A61K 31/4439
A61K 31/135

Abstract:

The present invention provides systems, compositions and methods for treatment of dopaminergic disorders (e.g., Parkinson's disease) using the combination of a first compound that inhibits a voltage-gated calcium channel of the type Ca1.3 (e.g., a dihydropyridine such as isradipine), and a second compound that is monoamine oxidase inhibitor and/or is a nitric oxide synthase inhibitor (e.g., rasagiline or derivative thereof).

US Patent:

20200323835, Oct 15, 2020

Filed:

Feb 12, 2020

Appl. No.:

16/788463

Inventors:

- Evanston IL, US
Javier Sanchez - Chicago IL, US
Jaime Guzman - Chicago IL, US
Enrico Zampese - Chicago IL, US
Daniel Galtieri - Chicago IL, US
Ema Ilijic - Chicago IL, US

International Classification:

A61K 31/4439
A61K 31/135

Abstract:

The present invention provides systems, compositions and methods for treatment of dopaminergic disorders (e.g., Parkinson's disease) using the combination of a first compound that inhibits a voltage-gated calcium channel of the type Ca1.3 (e.g., a dihydropyridine such as isradipine), and a second compound that is monoamine oxidase inhibitor and/or is a nitric oxide synthase inhibitor (e.g., rasagiline or derivative thereof).

US Patent:

20170182018, Jun 29, 2017

Filed:

Oct 11, 2016

Appl. No.:

15/290035

Inventors:

- Evanston, IL
Javier Sanchez - Chicago IL, US
Jaime Guzman - Chicago IL, US
Enrico Zampese - Chicago IL, US
Daniel Galtieri - Chicago IL, US
Ema Ilijic - Chicago IL, US

International Classification:

A61K 31/4439
A61K 31/135

Abstract:

The present invention provides systems, compositions and methods for treatment of dopaminergic disorders (e.g., Parkinson's disease) using the combination of a first compound that inhibits a voltage-gated calcium channel of the type Ca1.3 (e.g., a dihydropyridine such as isradipine), and a second compound that is monoamine oxidase inhibitor and/or is a nitric oxide synthase inhibitor (e.g., rasagiline or derivative thereof).

US Patent:

20140309260, Oct 16, 2014

Filed:

Apr 15, 2014

Appl. No.:

14/253528

Inventors:

- Evanston IL, US
Javier Sanchez - Chicago IL, US
Jaime Guzman - Chicago IL, US
Enrico Zampese - Chicago IL, US
Daniel Galtieri - Chicago IL, US
Ema Ilijic - Chicago IL, US

Assignee:

Northwestern University - Evanston IL

International Classification:

A61K 31/4439
A61K 31/135

US Classification:

514338

Abstract:

The present invention provides systems, compositions and methods for treatment of dopaminergic disorders (e.g., Parkinson's disease) using the combination of a first compound that inhibits a voltage-gated calcium channel of the type Ca1.3 (e.g., a dihydropyridine such as isradipine), and a second compound that is monoamine oxidase inhibitor and/or is a nitric oxide synthase inhibitor (e.g., rasagiline or derivative thereof).

Address:

11920 W Ridgeview Dr, Davie, FL 33330

Phone:

9543241999

VIN:

1G6DA1E35C0154461

Make:

CADILLAC

Model:

CTS

Year:

2012